English-language podcasts

Blood Podcast

Prospective Study for VTE and a Phase II Study on Sapablursen

15 min

Listen through the publisher, then discuss the episode here or arrange an in-person Roundtable. Your city determines where to meet.

Roundtables are designed for groups of four, with a shared subject and room for everyone to speak. Come for discussion, with no dating expectation.

In this week's episode, Blood editor Dr. Laura Michaelis interviews Dr. Sabine Eichinger of the Medical University of Vienna, and Dr. Jeanne Palmer of the Mayo Clinic on their latest articles published in Blood highlighting emerging research and treatment strategies in hematology. Dr. Eichinger discusses a prospective study examining the risk of recurrent venous thromboembolism (VTE) in patients with provoked thrombosis, revealing that recurrence rates were higher than previously estimated, particularly among patients with major transient risk factors. Her findings suggest that recurrence risk is not uniform and that anticoagulation duration should be individualized rather than based on a one-size-fits-all approach. Dr. Jeanne Palmer then reviews a Phase II clinical trial of sapablursin, a novel hepcidin mimetic for polycythemia vera, explaining how the agent regulates iron availability to reduce erythropoiesis, decrease phlebotomy requirements, and potentially improve patients' quality of life. Featured Articles: Risk of recurrence in patients with provoked venous thromboembolism: a prospective cohort study (https://ashpublications.org/blood/article-abstract/doi/10.1182/blood.2026034774/570098/Risk-of-recurrence-in-patients-with-provoked?redirectedFrom=fulltext) Sapablursen for erythrocytosis control in patients with polycythemia vera (https://ashpublications.org/blood/article/doi/10.1182/blood.2026033792/570260/Sapablursen-for-Erythrocytosis-Control-in-Patients)

Episode information is provided by the publisher. Listening takes place on the publisher’s service.

Listen at the source ↗

Featured places to meet in Palo Alto, CA

Explore these places and arrange a conversation through ThinkMatch.

City guide for Palo Alto, CA

More from Blood Podcast

Blood Podcast

Prothrombotic FVIII Mutation and Prime Editing T-Cells for Drug Resistance

31 min

In this week's episode, Blood editor Dr. Natalie Rosen interviews Dr. Lindsey George, Director of Clinical In Vivo Gene Therapy and an attending physician in the Division of Hematology at Children's Hospital of Philadelphia, and also Dr. Miles Horton and Dr. Thomas Lew of the Royal Melbourne Hospital and Peter McCallum Cancer Center, and the Walter and Eliza Hall Institute of Medical Research on their latest articles published in Blood on the characterization of the prothrombotic mechanisms of recombinant FVIII Aurora and turning immunosuppressants into tools for bidirectional in vivo control. Dr. George discusses "Factor VIII Aurora: a naturally occurring gain-of-function FVIII variant with enhanced FIXa affinity (https://ashpublications.org/blood/article-lookup/DOI/10.1182/blood.2026034515)" and Drs. Horton and Lew discuss "Prime editing enables drug-controllable T-cell therapies with clinical immunosuppression (https://ashpublications.org/blood/article-lookup/DOI/10.1182/blood.20260

Discuss this episode

Community Poll

Residents should help decide which activities are allowed in shared public spaces.

Share your view, then see how readers voted. No sign-in required. This poll is shared across stories.

Do you agree or disagree?

Choose one answer

Common Quandary

A Common Quandary to discuss

Another conversation to explore, separate from this news story.

Your neighbor's doorbell camera watches everyone entering your home. Is that their business?

A neighbor installs a doorbell camera that records your front yard and every visitor entering your home. They say the wide angle is necessary to capture package theft and the footage is rarely reviewed.

Where should private security stop in a shared public view?

Explore this quandary